Condition

Evans Syndrome clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Evans Syndrome clinical trials that are recruiting, at sites in 2 countries (most in China (2), France (1)). By phase: Phase 1/2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Evans Syndrome clinical trials

StudyPhaseWhereStatusRegistered
UCAR-T cells targeting CD19 and BCMA for autoimmune blood disorders Early Phase 1 Wuhan, Hubei Recruiting Mar 2, 2026
CM336 treatment for relapsed or refractory autoimmune cytopenia Phase 1/2 Zhengzhou, Henan and 2 other locations Recruiting Sep 16, 2025
National cohort for pediatric autoimmune cytopenia — Amiens and 8 other locations Recruiting Jul 10, 2023

All recruiting trials (3)

Related topics

Autoimmune Hemolytic AnemiaImmune ThrombocytopeniaImmune Thrombocytopenia (ITP)CAR-T

Quick answers

How many Evans Syndrome clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (2 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.